✦ LIBER ✦

Anti-metastatic efficacy and safety of MMI-166, a selective matrix metalloproteinase inhibitor

✍ Scribed by Ryuji Maekawa; Hideo Maki; Tohru Wada; Hiroshi Yoshida; Kazuyo Nishida-Nishimoto; Hiroyuki Okamoto; Yayoi Matsumoto; Hiroshige Tsuzuki; Takayuki Yoshioka

Book ID: 111564825
Publisher: Springer
Year: 2000
Tongue: English
Weight: 80 KB
Volume: 18
Category: Article
ISSN: 0262-0898
DOI: 10.1023/a:1026553414492

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Augmented anti-metastatic efficacy of a

Augmented anti-metastatic efficacy of a selective matrix metalloproteinase inhibitor, MMI-166, in combination with CPT-11

✍ Hideo Maki; Kanji Hojo; Hidekazu Tanaka; Takuko Yamada Sawada; Ryuji Maekawa; Ta 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 153 KB

Anti-invasive Effect of MMI-166, a New S

Anti-invasive Effect of MMI-166, a New Selective Matrix Metalloproteinase Inhibitor, in Cervical Carcinoma Cell Lines

✍ Masahiro Iwasaki; Akira Nishikawa; Takashi Fujimoto; Noriyuki Akutagawa; Kengo M 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 116 KB

Antitumor effect of a new selective matr

Antitumor effect of a new selective matrix metalloproteinase inhibitor, MMI-166, on experimental pancreatic cancer

✍ A. Matsushita; M. Onda; E. Uchida; R. Maekawa; T. Yoshioka 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 402 KB

The antitumor effect of a new matrix metalloproteinase inhibitor, MMI-166, which is a selective inhibitor of MMP-2 and -9, was examined in the hamster pancreatic cancer cell line PGHAM-1. In vitro, MMI-166 inhibited the gelatinase activity of MMP-2 and -9 derived from PGHAM-1 cells, and dose-depende

Prevention of liver metastasis of human

Prevention of liver metastasis of human colon cancer by selective matrix metalloproteinase inhibitor MMI-166

✍ Kouji Oba; Hiroyuki Konno; Tatsuo Tanaka; Megumi Baba; Kinji Kamiya; Manabu Ohta 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 346 KB

Anti-metastatic and anti-angiogenic acti

Anti-metastatic and anti-angiogenic activities of a new matrix metalloproteinase inhibitor, TN-6b

✍ S.J. Lee; H. Sakurai; K. Oshima; S.H. Kim; I. Saiki 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 429 KB

Reduction of in vivo tumor growth by MMI

Reduction of in vivo tumor growth by MMI-166, a selective matrix metalloproteinase inhibitor, through inhibition of tumor angiogenesis in squamous cell carcinoma cell lines of head and neck

✍ Hideaki Katori; Yuh Baba; Yukari Imagawa; Goshi Nishimura; Yuumi Kagesato; Emi T 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 352 KB